Ramdas Borhade: IL-17, Endothelial Activation and Thrombosis Prediction in Cancer
Ramdas Borhade, Deputy General Manager at Murali Krishna Pharma PVT LTD, shared on LinkedIn about a recent article by Dimitra Karagkouni et al, published in Science Translational Medicine, adding:
”Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation | Science Translational Medicine.”
Title: Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation
Authors: Dimitra Karagkouni, Marisa A. Brake, Rushad Patell, Anna Falanga, Marina Marchetti, Laura Russo, Simon Mantha, Donna Neuberg, Thita Chiasakul, Marc Carrier, Philip S. Wells, Robert E. Gerszten, Robert Flaumenhaft, Daniel Hui, Ioannis S. Vlachos, Sol Schulman, Jeffrey I. Zwicker
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 3, 2026, 16:01Your First Steps After an ITP Diagnosis – ITP Support Association
-
Aug 3, 2026, 15:33Christina Crossette-Thambiah: Scientific Excellence and Mentorship at ISTH 2026
-
Aug 3, 2026, 15:22Connie Montgomery: Why Global Support is Essential for the HFA Black Voices Initiative
-
Aug 3, 2026, 15:18Ifeanyichukwu Ifechidere: The DOAC Monitoring Masterclass
-
Aug 3, 2026, 15:02David McIntosh: UK Plasma Action – a Founder’s Reflections
-
Aug 3, 2026, 14:49Ney Carter Borges: Targeting the Gut Microbiome to Prevent Atrial Fibrillation
-
Aug 3, 2026, 13:42Immune Thrombocytopenia: Moving Beyond Platelet Counts Toward Durable Remission
-
Aug 3, 2026, 13:28Aboo Shama Khan: Pulmonary Embolism – A Medical Emergency Every Nurse Must Recognize
-
Aug 3, 2026, 13:08Ashwin Patel: Evaluating Red Cell Function Post-Treatment in SCD Patients